Who
Dean Zikria
Interim CEO
Company insider
Files Form 4 as: Interim CEO, Valion Bio.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Dec 2021
- Last trade
- 22 Sep 2026
- Last filed
- 24 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Sep 2026filed 24 Sep 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 22 Sep 2026filed 24 Sep 2026 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 6 Aug 2025filed 8 Aug 2025 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —7,500 at $0.00 | filing |
| 18 Dec 2024filed 20 Dec 2024 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —12,000 at $0.00 | filing |
| 9 Aug 2024filed 13 Aug 2024 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —3,000 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 14 Jun 2022filed 21 Jun 2022 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 14 Jun 2022filed 16 Jun 2022 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 14 Dec 2021filed 16 Dec 2021 | VBIO Valion Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —18,000 at $0.00 | filing |
News
Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitionscaliforniatelegraph.com · 23 Sep 2026
1 headline in the last 90 days name Dean Zikria; no company of theirs resolves to a name we track.
Sectors
No trade we could place in a sector.